CS203352B1 - Method of treatment of fermentation substrate - Google Patents
Method of treatment of fermentation substrate Download PDFInfo
- Publication number
- CS203352B1 CS203352B1 CS56978A CS56978A CS203352B1 CS 203352 B1 CS203352 B1 CS 203352B1 CS 56978 A CS56978 A CS 56978A CS 56978 A CS56978 A CS 56978A CS 203352 B1 CS203352 B1 CS 203352B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- cephalosporin
- pat
- urea
- fermentation broth
- fermentation
- Prior art date
Links
- 238000000855 fermentation Methods 0.000 title claims description 20
- 230000004151 fermentation Effects 0.000 title claims description 20
- 238000000034 method Methods 0.000 title claims description 18
- 239000000758 substrate Substances 0.000 title 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 10
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 9
- 239000004202 carbamide Substances 0.000 claims description 9
- 238000000746 purification Methods 0.000 claims description 8
- 239000003599 detergent Substances 0.000 claims description 7
- 229930186147 Cephalosporin Natural products 0.000 claims description 5
- 229940124587 cephalosporin Drugs 0.000 claims description 5
- 150000001780 cephalosporins Chemical class 0.000 claims description 5
- 230000015572 biosynthetic process Effects 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims description 2
- HOKIDJSKDBPKTQ-GLXFQSAKSA-N cephalosporin C Chemical compound S1CC(COC(=O)C)=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CCC[C@@H](N)C(O)=O)[C@@H]12 HOKIDJSKDBPKTQ-GLXFQSAKSA-N 0.000 description 22
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- 239000002689 soil Substances 0.000 description 4
- 239000002594 sorbent Substances 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 241001619326 Cephalosporium Species 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000002028 Biomass Substances 0.000 description 1
- 241000228417 Sarocladium strictum Species 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000002156 adsorbate Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229940088623 biologically active substance Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- FVEFRICMTUKAML-UHFFFAOYSA-M sodium tetradecyl sulfate Chemical compound [Na+].CCCCC(CC)CCC(CC(C)C)OS([O-])(=O)=O FVEFRICMTUKAML-UHFFFAOYSA-M 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
Landscapes
- Cephalosporin Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
(54) Spósob úpravy farmentačnoj pódy ·(54) Treatment method farmentačnoj pody ·
Vynález sa týká sposobu úpravy fermentačnej p3dy před izoláciou cefalosporínu C, na syntetických živiciach.The invention relates to a process for treating fermentation broth prior to isolation of cephalosporin C on synthetic resins.
Získanie cefalosporínu C čistěním ferměntačnej p6dy navazuje na jeho fermentačnú přípravu pomocou mikroorganizmov rodu Cephalosporium, napr. kmeúom Cephalosporium acremonium ATCC 14 553, pričom médium obsahuje biologicky aktívnu látku /Crawford K. a kol.: Antibiotics production by a species of Cephalosporium. J. Gen. Microbiol. £ /1952/, str. 47-59; Hewitt W.The recovery of cephalosporin C by purification of the fermentation broth follows its fermentation preparation using microorganisms of the genus Cephalosporium, e.g. strain Cephalosporium acremonium ATCC 14 553, wherein the medium contains a biologically active substance / Crawford K. et al .: Antibiotics production by a species of Cephalosporium. J. Gen. Microbiol. £ (1952), p. 47-59; Hewitt W.
L.: The cephalosporins. The Journal of infections Piseares 128, /1973/. str. 312.L .: The Cephalosporins. The Journal of Infections Piseares 128 (1973). p. 312th
Takéto fermentačné postupy sa uvádzajú tiež napr. vo švajčiarskych patentoch č. 570 460, č. 565 246, č. 570 459, v britských patentoch č. 820 422, v US patente č. 3 082 155 a v patente NSR č. 1 492 053. V týchto patentoch sa uvádzajú tiež určité postupy na získanie a čistenie cefalosporínu C zo surověj fermentačnej pódy.Such fermentation processes are also disclosed e.g. U.S. Pat. 570 460, no. 565 246, no. No. 570,459, in British Pat. 820,422, U.S. Pat. 3,082,155 and in German patent no. These patents also disclose certain processes for recovering and purifying cephalosporin C from a crude fermentation stage.
Spósoby čistenia cefalosporínu C z fermentačnej pódy cez* N-deriváty .například N-haloalkanoyl, alebo N-benzoyl, extrahujúce sa vhodnými organickými rozpúštadlami sú popísané v US pat. č. 3 739 002, č. 3 835 129, v pat. NSR č. 2 255 973, č. 2 157 693 a v pat. ZSSR číslo 282 174.Methods for purifying cephalosporin C from the fermentation broth via N-derivatives such as N-haloalkanoyl or N-benzoyl, extracted with suitable organic solvents, are described in US Pat. no. No. 3 739 002, no. No. 3,835,129, in U.S. Pat. NSR no. 2 255 973, no. 2,157,693 and in U.S. Pat. USSR number 282 174.
Významnou skupinou izolačnýeh postupov sú spósoby založené na deiení pomocou syntetických ionexov, napr. franc. pat. 6. 1 353 113, brit pat. č. 1 210 823, č. 1 036 125, resp. australsky pat. č. 251 922, 455 753, švéd. pat. č. 198 707, 215 561, 198 707, 541 579.An important group of isolation procedures are synthetic ion exchange methods, e.g. France. pat. 6. 1,353,113, British Pat. no. 1 210 823, no. 1,036,125, respectively. Australian Pat. no. 251 922, 455 753, Sweden. pat. no. 198,707, 215,561, 198,707, 541,579.
Hydrofilné antibiotiká, napr. cefalosporín C, sa móžu zo zložitých suspenzných fermentačných pód obsahujúcich velké množstvo rozpuštěných organických a anorganických zlúčenín získat pomocou makroporéznych neionogenných sorbentov, napr. typu Amberlit XAD-2, Ostion SP-1, Diaion HP-20.Hydrophilic antibiotics, e.g. cephalosporin C, can be obtained from complex suspension fermentation stages containing a large amount of dissolved organic and inorganic compounds using macroporous non-ionic sorbents, e.g. Type Amberlit XAD-2, Ostion SP-1, Diaion HP-20.
Izolácie pomocou týchto sorbentov sú úvádzané napr. v US pat. č. 3 725 400, resp. ZSSR pat. č. 350 265.Insulations with these sorbents are contemplated e.g. in US Pat. no. 3,725,400, respectively. USSR pat. no. 350 265.
Podmienkou zdárného priebehu izolácie na živiciach jé předpoklad mat k dispozfcii čirý bThe condition of a successful isolation process on the resins is the assumption that clear b
filtrát, ktorý slúži ako nástrek na hlavu kolon. Pri čistění cefalosporinů C sa pomocou anorganických kyselin upravuje pH na 2,7! čím sa má vyvolat koagulácia bielkovín.filtrate, which serves as a spray on the head of the columns. In the purification of cephalosporins C, the pH is adjusted to 2.7 with inorganic acids. thereby causing protein coagulation.
Po filtrác*ii v priebehu adsorpcie dochádza však k postupnému ďalšiemu koagulovániu níektorýeh rozpustných látok, hlavně bielkovín, pričom takto znečistěný filtrát znižuje kapacitu sorbentov a stažuje další priebeh izolačného postupu včítane regenerácie sorhentov.However, after filtration during the adsorption, there is a gradual further coagulation of some soluble substances, mainly proteins, whereby the impure filtrate reduces the capacity of the sorbents and withdraws the further course of the isolation process, including the regeneration of the sorhents.
Hoře uvedená nedostatky odstraňuje spósob úpravy fermentačnej p3dy, ktorého podstata spočívá v tom, že k fermentačnej póde po biosyntéze cefalosporinů C sa přidá pri pH 2,5-4,0 5 až 30 mg/ml močoviny,' póda sa sfiltruje a podrobí ďalšej purifikácii. Postup sa móže doplnit ešte prídavkom 0,5 až 52 anionaktívneho detergentu.The above-mentioned drawbacks eliminate the method of treatment of the fermentation broth, which consists in adding to the fermentation broth after the cephalosporin C biosynthesis at a pH of 2.5-4.0 5 to 30 mg / ml urea, filtering and subjecting the pod to further purification . The process may be supplemented by the addition of 0.5-52 anionic detergent.
močovině je známe, že móže u niektorých labilných nekovalentných vázieb rušit terciálnu Strukturu bielkovín a tým spósobit ich denaturáciu.It is known in the urea that, in some labile non-covalent bonds, it can disrupt the tertiary structure of proteins and thereby cause their denaturation.
Tento denaturačný efekt je velmi potřebný, pretože pre malú termostabilitu cefalosporín C nie je reálna termokoagulácia surověj fermentačnej pódy.,This denaturation effect is very needed because, due to the low thermostability of cephalosporin C, the thermoagulation of the raw fermentation broth is not realistic.
Prídavok tejto látky spóaobuje zniženie obsahu rozpuštěných proteinov v získanom filtráte, čo v konečnom efekte zlepšuje adsorpčnú kapacitu a tiež regeneráciu použitých živic.The addition of this material results in a reduction in the dissolved protein content of the filtrate obtained, which ultimately improves the adsorption capacity as well as the regeneration of the resins used.
Anionaktívne detergenty okrem čistiaceho účinku pósobia aj ako antibakteriálne látky, čo je velmi dóležité ako prevencia před možnou mikrobiálnou kontamináciou náplní stlpcov.In addition to the cleaning effect, anionic detergents also act as antibacterial agents, which is very important as a prevention of possible microbial contamination of column fillings.
V tejto skupině detergentov tvoria velkú skupinu přídavky, ktorých hlavným podielom je laurylsulfát sodný. Komerčně sa osvědčil najmá TERGITOL.In this group of detergents, a large group of additives are made up, the major part being sodium lauryl sulfate. TERGITOL, in particular, has proven commercially.
V dalšom je vynález bližšie objasněný v prikladoch postupov bez toho, že by sa na tieto akokolvek obmedzoval.In the following, the invention is explained in more detail in the examples of procedures without being limited thereto.
Přiklad 1Example 1
Surová fermentačná póda sa upraví 10 mg močoviny na 1 ml pódy, 15 minút mieša a potom okyselí s kyselinou sírovou ztiedenou v pomere 1:4 na pH 2,5. Biomasa a ďalšie nerozpustné zložky sa filtráciou oddelia od hnedo sfarbeného čirého filtrátu, obsahujúceho 3 600 «ag/ml cefalosporínu C.The crude fermentation platform is adjusted with 10 mg of urea per ml of soil, stirred for 15 minutes and then acidified with a 1: 4 dilution of sulfuric acid to pH 2.5. The biomass and other insoluble ingredients are separated from the brown colored clear filtrate containing 3600 g / ml cephalosporin C by filtration.
000 ml tohoto filtrátu sa perkoluje cez 3 970 ml náplně živice Ostion SP-1 pri mernora zataženi 1 h Zbytok adsorbátu z náplně sa vytěsní 2 000 ml vody a neviazaný cefalosporín C desorbujeme 152yným vodným roztokom acetonu.000 ml of this filtrate was percolated through a 3 970 ml Ostion SP-1 resin cartridge at a mernor load of 1 h. The adsorbate residue was displaced from the cartridge by 2,000 ml of water and desorbed with unbound cephalosporin C with a 152% aqueous acetone solution.
Získá se 3 060 ml eluátu s obsahom 5 000 ^ug/ml cefalosporinů C, ktorý sa podrobí dalšej purifikácii.3060 ml of an eluate containing 5,000 µg / ml of cephalosporins C are obtained, which is subjected to further purification.
Použitý Ostion SP-, sa regeneruje 12 1 252-ného vodného roztoku acetonu s obsahom 22 NaOH. Potom sa náplň premyje 2 1 12-nej kyseliny sírovej a nakoniec 12 1 vody.The Ostion SP- used was regenerated with 12 L of a 252 N aqueous solution of acetone containing 22 NaOH. The cartridge was then washed with 2 L of 12-L sulfuric acid and finally with 12 L of water.
Příklad 2Example 2
Spósob ako v příklade 1, s tým rozdielom, že k surověj fermentačnej póde sa přidá 5 mg močoviny na 1 ml pódy a cefalosporín C sa zo živice eluuje 0,05 N vodným roztokom NaOH. Na 4 000 ml Ostionu SP-1 sa adsorbuje 5 450-ml čirého filtrátu obsahujúceho 3 100 yug/ml cefalosporínu C. Tento sa desorbuje zo sorbentu 0,05 N vodným roztokom NaOH, pričom v 3 800 ml eluátových podieloch sa získá 82 2 z celkového množstva cefalosporinů C.Method as in Example 1, except that 5 mg of urea per ml of soil was added to the crude fermentation broth and cephalosporin C was eluted from the resin with 0.05 N aqueous NaOH. 5 450-ml of a clear filtrate containing 3 100 µg / ml of cephalosporin C is adsorbed onto 4000 ml of Ostion SP-1. This is desorbed from the sorbent with 0.05 N aqueous NaOH, yielding 82 2 of the 3 800 ml eluates. total amount of Cephalosporins C.
Příklad 3Example 3
Spósob ako v příklade 1, s tým rozdielom, že k surověj fermentačnej póde sa přidá 30 mg močoviny na 1 ml pódy a pH sa upraví s kyselinou sírovou na 2,9 /1:4/. Získaný čirý filtrát sa podrobí ďalšej purifikácii na Ostione SP-1.Method as in Example 1, except that 30 mg of urea per ml of soil was added to the crude fermentation broth and the pH was adjusted to 2.9 (1: 4) with sulfuric acid. The clear filtrate obtained is subjected to further purification on Ostion SP-1.
Příklad 4Example 4
Spósob ako v příklade 1, len s tým rozdielom, že k surověj fermentačnej póde sa přidá 10 mg močoviny na 1 ml pódy a 0,5 promile anionaktívneho detergentu Tergitolu. Takto upravená surová fermentačná póda sa sfiltruje a čirý filtrát podrobí ďalšej purifikácii.Method as in Example 1, except that 10 mg of urea per ml of soil and 0.5 per mille of anionic detergent Tergitol are added to the crude fermentation broth. The crude fermentation platform thus treated is filtered and the clear filtrate subjected to further purification.
Příklad 5Example 5
Sposob ako v příklade 1, s tým rozdielom, že k surověj fermentačnej póde sa přidá 5 mg/ml močoviny a 5 promile, anionaktívneho detergentu Tergitolu a pH sa upraví na 4,0 s kyselinou sírovou /1:4 /. Takto upravená fersnentačná podá sa sfiltruje a filtrát podrobí ďalšej purifikácii.Method as in Example 1, except that 5 mg / ml urea and 5 per mille of anionic detergent Tergitol are added to the crude fermentation broth and the pH is adjusted to 4.0 with sulfuric acid (1: 4). The treated fermentation is then filtered and the filtrate subjected to further purification.
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS56978A CS203352B1 (en) | 1978-01-27 | 1978-01-27 | Method of treatment of fermentation substrate |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS56978A CS203352B1 (en) | 1978-01-27 | 1978-01-27 | Method of treatment of fermentation substrate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS203352B1 true CS203352B1 (en) | 1981-02-27 |
Family
ID=5337989
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS56978A CS203352B1 (en) | 1978-01-27 | 1978-01-27 | Method of treatment of fermentation substrate |
Country Status (1)
| Country | Link |
|---|---|
| CS (1) | CS203352B1 (en) |
-
1978
- 1978-01-27 CS CS56978A patent/CS203352B1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US2528022A (en) | Purification of antibiotics by ion exchange procedures | |
| DK173231B1 (en) | Method for Extraction of Glycopeptidic Antibiotics | |
| US4440753A (en) | Purification of glycopeptide antibiotics using non-functional resins | |
| DE2021696C3 (en) | Method of Isolating Cephalosporin C. | |
| CA1283072C (en) | Process for the isolation and separation of lysozyme and avidin from eggwhite | |
| CH660012A5 (en) | PROCEDURE FOR THE PURIFICATION OF THYLOSIN. | |
| DE69629551T2 (en) | COMBINED PROCESS FOR PURIFYING VANCOMYCIN HYDROCHLORIDE | |
| CH370871A (en) | Process for obtaining an antibiotic fermentation product from a fermentation broth | |
| DE69628002T2 (en) | PRODUCTION OF CLAVUNALATE SALTS | |
| JP3083369B2 (en) | Teicoplanin recovery method | |
| SK287315B6 (en) | A method for polymyxin B isolation from fermented soil | |
| DE60124868T2 (en) | NEW RESINS AND THEIR USE FOR THE RECOVERY OF PROTEINS OR PEPTIDES | |
| US5061627A (en) | Method for preparing enzymes from crustaceans | |
| Zittle et al. | Use of butanol in the purification of the alkaline phosphatase of bovine milk | |
| CS203352B1 (en) | Method of treatment of fermentation substrate | |
| DE68911503T2 (en) | RECOVERY OF UROKINASE COMPOUNDS. | |
| US5215908A (en) | Process for recovery and purification of chymosin | |
| JPS6160050B2 (en) | ||
| JPH01112987A (en) | Avoparcin which doesn't contain highly effective biomass and method for its manufacture | |
| DE2555587C3 (en) | Procedure for the extraction and collection of kallidinogenase | |
| DE4318235B4 (en) | Process for the preparation of high purity deferoxamine salts | |
| US2834711A (en) | Production of bacitracin | |
| DE3922278A1 (en) | METHOD FOR PRODUCING FREE EPSILON POLYLYSINE | |
| KR900009053B1 (en) | Method for preparing avoparsin alkyl sulfate complex compound of mycelium free high titer | |
| US2540238A (en) | Purification and recovery of streptomycin |